1. Home
  2. SEPN vs KRUS Comparison

SEPN vs KRUS Comparison

Compare SEPN & KRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • KRUS
  • Stock Information
  • Founded
  • SEPN 2022
  • KRUS 2008
  • Country
  • SEPN United States
  • KRUS United States
  • Employees
  • SEPN N/A
  • KRUS N/A
  • Industry
  • SEPN
  • KRUS Restaurants
  • Sector
  • SEPN
  • KRUS Consumer Discretionary
  • Exchange
  • SEPN NYSE
  • KRUS Nasdaq
  • Market Cap
  • SEPN 1.0B
  • KRUS 915.2M
  • IPO Year
  • SEPN 2024
  • KRUS 2019
  • Fundamental
  • Price
  • SEPN $22.53
  • KRUS $89.22
  • Analyst Decision
  • SEPN
  • KRUS Buy
  • Analyst Count
  • SEPN 0
  • KRUS 8
  • Target Price
  • SEPN N/A
  • KRUS $84.88
  • AVG Volume (30 Days)
  • SEPN 399.2K
  • KRUS 207.6K
  • Earning Date
  • SEPN 11-26-2024
  • KRUS 01-02-2025
  • Dividend Yield
  • SEPN N/A
  • KRUS N/A
  • EPS Growth
  • SEPN N/A
  • KRUS N/A
  • EPS
  • SEPN N/A
  • KRUS N/A
  • Revenue
  • SEPN $838,000.00
  • KRUS $237,860,000.00
  • Revenue This Year
  • SEPN N/A
  • KRUS $20.49
  • Revenue Next Year
  • SEPN N/A
  • KRUS $20.52
  • P/E Ratio
  • SEPN N/A
  • KRUS N/A
  • Revenue Growth
  • SEPN N/A
  • KRUS 26.91
  • 52 Week Low
  • SEPN $18.62
  • KRUS $48.66
  • 52 Week High
  • SEPN $26.34
  • KRUS $122.81
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • KRUS 46.90
  • Support Level
  • SEPN N/A
  • KRUS $88.41
  • Resistance Level
  • SEPN N/A
  • KRUS $95.44
  • Average True Range (ATR)
  • SEPN 0.00
  • KRUS 6.26
  • MACD
  • SEPN 0.00
  • KRUS -1.53
  • Stochastic Oscillator
  • SEPN 0.00
  • KRUS 4.60

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About KRUS Kura Sushi USA Inc.

Kura Sushi USA Inc is a Japanese restaurant company. It operates revolving sushi chain restaurants in the United States. It provides access to the revolving and express conveyor belts, on-demand ordering screen, plate slot, and the Bikkura-Pon rewards machine. The company offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, Salmon, among others. Geographically, it derives revenue from the United States of America.

Share on Social Networks: